Artelo Common Stock Total Equity from 2010 to 2026
| ARTL Stock | USD 1.47 0.10 7.30% |
Common Stock Total Equity | First Reported 2014-06-30 | Previous Quarter 22.2 K | Current Value 23.1 K | Quarterly Volatility 5.5 K |
Check Artelo Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Artelo Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 2.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.9. Artelo financial statements analysis is a perfect complement when working with Artelo Biosciences Valuation or Volatility modules.
Artelo | Common Stock Total Equity | Build AI portfolio with Artelo Stock |
Historical Common Stock Total Equity data for Artelo Biosciences serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Artelo Biosciences represents a compelling investment opportunity.
Latest Artelo Biosciences' Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of Artelo Biosciences over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Artelo Biosciences' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Artelo Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
Artelo Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 6,453 | |
| Geometric Mean | 6,079 | |
| Coefficient Of Variation | 40.40 | |
| Mean Deviation | 1,741 | |
| Median | 6,000 | |
| Standard Deviation | 2,607 | |
| Sample Variance | 6.8M | |
| Range | 10.6K | |
| R-Value | (0.21) | |
| Mean Square Error | 6.9M | |
| R-Squared | 0.04 | |
| Significance | 0.41 | |
| Slope | (109.41) | |
| Total Sum of Squares | 108.7M |
Artelo Common Stock Total Equity History
About Artelo Biosciences Financial Statements
Artelo Biosciences investors utilize fundamental indicators, such as Common Stock Total Equity, to predict how Artelo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 4.5 K | 6.3 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Artelo Biosciences Correlation against competitors. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Artelo Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Artelo Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Artelo Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Artelo Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.